WHO Approves Two New Drug to Treat COVID-19

Daily Current Affairs / WHO Approves Two New Drug to Treat COVID-19

Change Language English Hindi

Category : International Published on: January 17 2022

Share on facebook

The World Health Organization has approved two new drugs for two new COVID-19 treatments that will help expand its arsenal of vaccines as well as tools to prevent serious illness and virus deaths.
These two drug are baricitinib and casirivimab-imdevimab.
The WHO has recommended Eli Lilly & Co.’s rheumatoid arthritis drug and GlaxoSmithKline Plc’s monoclonal antibody.
Lilly's baricitinib drug is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis.

India strikes terror camps in Pakistan and PoK in response to Pahalgam killings; flights at 13 northern airports cancelled till May 10.
Read More....
PM Modi calls space a symbol of curiosity and unity at Global Space Conference 2025.
Read More....
India-UK free trade deal finalized, aiming for $34 billion trade by 2040.
Read More....
India’s co-working space to grow to 125 million sq. ft. by 2027; five IPOs to raise ₹7,000 crore. Hindi:
Read More....
CM Stalin to lead May 10 rally supporting armed forces, condemning Pakistan’s actions.
Read More....
SECL hosts first ‘Sneh Milan Mela’ in Chhattisgarh to strengthen ties with local communities.
Read More....
World Red Cross Day to be observed on May 8 to honor humanitarian efforts worldwide.
Read More....
India rolls out chip-based e-passports for secure and biometric global travel.
Read More....
First geothermal well in Northeast drilled in Arunachal to power eco-friendly agricultural solutions.
Read More....
Brazil to host 2027 Women’s World Cup; Maracana among 8 FIFA-announced venues.
Read More....

WHO Approves Two New Drug to Treat COVID-19